Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Efficacy of a Probiotic Mixture in Subjects With Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

NCT07193927 is registered in ClinicalTrials.gov with AB Biotics, SA as lead sponsor.

NCT NCT07193927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Efficacy of a Probiotic Mixture in Subjects With Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
Lead sponsor
AB Biotics, SA
Phase
Phase 2
Overall status
Recruiting
Start date
March 20, 2026
Completion date
June 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver disease, nonalcoholic, masld - metabolic dysfunction-associated steatotic liver disease, overweight (bmi > 25)